- Buzz
- 28 February 2025
Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says
Stifel initiated coverage on Compass Pathways plc, saying, “The Time Is Now for Psychedelics....
- Buzz
- 27 February 2025
New Study Suggests Medical Cannabis Highly Cost-Effective Treatment for PTSD
Medical cannabis is a highly cost-effective treatment for individuals with moderate post-traumatic...
- Buzz
- 27 February 2025
UW study is looking at marijuana use in pregnancy
What, if any, are the impacts on infants if a pregnant person regularly uses marijuana during...
- Buzz
- 26 February 2025
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
Enveric Biosciences has secured its first U.S. patent for the EVM401 Series, a novel collection of...
- Buzz
- 25 February 2025
Nearly Half of Canadian Cannabis Contains Just 80% of Advertised THC Levels
Canada’s pioneering Cannabis Data Gathering Program has published the results of a new study...
- Buzz
- 25 February 2025
Daily Cannabis use linked to cannabinoid hyperemesis syndrome: Study
Washington DC [US], February 24 (ANI): A new study analyzed the disease burden and risk factors for...
- Buzz
- 24 February 2025
Medical Cannabis Bringing Relief To Minnesota Pain Patients
A recent report from Minnesota’s Office of Cannabis Management indicates many patients are finding...
- Buzz
- 21 February 2025
Beyond Chronic Pain: Why Private Clinics are Vital to Making Medical Cannabis Mainstream
The medical cannabis industry is in a precarious situation. The fledgling market is experiencing...
- Buzz
- 20 February 2025
Newsweek: PHI’s Dr. Meenakshi Subbaraman Discusses the Increased Demand of Cannabis-Infused Beverages and Health Risks
- Buzz
- 19 February 2025
Doctors Ask US Appellate Court for Redo in DEA’s Selections for Cannabis Rescheduling Participants
A nonprofit organization of medical professions in support of evidence-based cannabis regulation...